BG
ARVN icon

Bellevue Group’s Arvinas ARVN Stock Holding History

Bellevue Group’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,389,600
Closed -$45.8M – 150
2024
Q4 		$45.8M Buy
2,389,600
+3,000
+0.1% +$72.9K 0.88% 26
2024
Q3 		$58.8M Sell
2,386,600
-4,200
-0.2% -$110K 0.95% 27
2024
Q2 		$63.6M Hold
2,390,800
– – 1.03% 24
2024
Q1 		$98.7M Sell
2,390,800
-116,931
-5% -$5.11M 1.51% 20
2023
Q4 		$103M Buy
2,507,731
+382,531
+18% +$8.94M 1.58% 16
2023
Q3 		$41.7M Sell
2,125,200
-1,800
-0.1% -$44.2K 0.67% 45
2023
Q2 		$52.8M Hold
2,127,000
– – 0.75% 39
2023
Q1 		$58.1M Sell
2,127,000
-23,412
-1% -$740K 0.84% 41
2022
Q4 		$73.6M Sell
2,150,412
-40,350
-2% -$1.7M 0.98% 31
2022
Q3 		$97.5M Buy
2,190,762
+66,486
+3% +$3.23M 1.4% 18
2022
Q2 		$89.4M Sell
2,124,276
-54,977
-3% -$2.76M 1.26% 22
2022
Q1 		$147M Sell
2,179,253
-54,150
-2% -$3.69M 1.7% 14
2021
Q4 		$183M Sell
2,233,403
-8,000
-0.4% -$651K 1.89% 14
2021
Q3 		$184M Buy
2,241,403
+4,000
+0.2% +$354K 1.87% 11
2021
Q2 		$172M Buy
2,237,403
+165,900
+8% +$11.5M 1.68% 14
2021
Q1 		$137M Sell
2,071,503
-120,000
-5% -$9.18M 1.45% 17
2020
Q4 		$186M Buy
2,191,503
+550,000
+34% +$19M 2.13% 10
2020
Q3 		$38.8M Buy
1,641,503
+59,800
+4% +$1.73M 0.54% 54
2020
Q2 		$53.1M Buy
1,581,703
+312,400
+25% +$13.3M 0.75% 39
2020
Q1 		$51.2M Buy
1,269,303
+27,400
+2% +$1.28M 0.99% 27
2019
Q4 		$51M Buy
1,241,903
+435,500
+54% +$12.7M 0.81% 37
2019
Q3 		$17.4M Buy
+806,403
New +$19.8M 0.32% 63

Other funds holding ARVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Bellevue Group's ARVN Position: Q1 2025 in Review

Bellevue Group sold out of Arvinas (ARVN) in Q1 2025, closing a stake of 2,389,600 shares — an estimated $45.8M sold.

Bellevue Group first reported a position in ARVN in Q3 2019 and held it in 22 quarters. The position peaked at $186M in Q4 2020. 215 funds tracked by Wall St. Rank hold ARVN as of Q1 2025.

  • Bellevue Group reported no remaining Arvinas position as of Q1 2025 after selling out during the quarter.
  • Bellevue Group sold 2,389,600 Arvinas shares in Q1 2025, an estimated $45.8M.
  • Bellevue Group first reported a position in Arvinas in Q3 2019 and held it in 22 quarters.
  • Bellevue Group's Arvinas position peaked at $186M in Q4 2020.
  • 215 funds tracked by Wall St. Rank held Arvinas as of Q1 2025.

Based on Bellevue Group's 13F filing for Q1 2025, filed 14 May 2025.